Institute for Neurodegenerative Disorders
New Haven, Connecticut, 06510, United States
NCT Number: NCT00096876
In this study, individuals complete and return a mail survey, specifically a 40 item scratch and sniff smell test.
Looking for future studies?
Notify Me21 year and older
All sexes
Observational
New Haven, Connecticut, 06510, United States
This study would extend the findings of previous studies by characterizing the performance of the 40-item UPSIT in a cohort of first-degree relatives of Parkinson's disease (PD) patients. The results would also validate the use of the University of Pennsylvania Smell Identification Test (UPSIT) as a mail-survey instrument. Once identified, these individuals could be followed as a potentially at-risk cohort to determine if the screening evaluation was predictive of later developing Parkinson's disease. The results from this pilot study have the potential to guide the use of olfactory testing using the UPSIT as a screening tool, and to provide necessary preliminary data for planning clinical trials to prevent the occurrence of PD in at-risk individuals.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Institute for Neurodegenerative Disorders
Other
Screening Evaluations for Neurologic Syndromes: Olfactory Testing in Relatives of Parkinson's Disease Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04925622
Autonomic Nervous System Diseases, Basal Ganglia Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT04974034
Akinesia, Basal Ganglia Diseases
Bobigny, Seine Saint Denis, France
View Trial DetailsNCT00273351
Basal Ganglia Diseases, Brain Diseases
New Haven, Connecticut, United States
View Trial DetailsNCT00096720
Basal Ganglia Diseases, Brain Diseases
Oxnard, California, United States
View Trial Details